Form 4: Aspen Aerogels CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Aspen Aerogels' President and CEO, Donald R. Young, sold 56,845 shares of common stock for tax purposes under a pre-arranged 10b5-1 trading plan.
Summary
- Donald R. Young, President and CEO of Aspen Aerogels Inc. (ASPN), reported the sale of 56,845 shares of common stock.
- The transaction occurred on November 13, 2025, at an average price of $3.23 per share, with prices ranging from $3.15 to $3.41.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Young on August 11, 2025.
- The stated purpose of the sale was for tax purposes in connection with a one-time personal real estate transaction.
- Following this transaction, Mr. Young beneficially owns 494,011 shares, comprising 414,306 shares of Common Stock and 79,705 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While it's an insider sale, which can be perceived negatively, the fact that it's under a 10b5-1 plan for personal tax/real estate reasons mitigates the negative signal, suggesting it's not based on a lack of confidence in the company's performance.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new, undisclosed material information.
- The stated reason for the sale is for tax purposes related to a personal real estate transaction, suggesting it is not a reflection of a lack of confidence in the company's future.
Negatives
- A significant sale of 56,845 shares by the President and CEO, even if planned, could be perceived negatively by some investors, potentially signaling a reduction in insider exposure.
Risks
- Investor sentiment could be negatively impacted by the perception of insider selling, regardless of the stated personal reasons for the transaction.
Management Comments
- The transaction was effected pursuant to a Rule 10b5-1 trading plan, previously adopted on August 11, 2025, to sell a limited number of shares for tax purposes in connection with a one-time personal real estate transaction.
Industry Context
Insider transactions, particularly sales by high-ranking executives, are closely watched by the market as they can sometimes signal management's perception of the company's future prospects. However, sales made under pre-arranged 10b5-1 plans for personal financial planning reasons are generally viewed as less indicative of a change in company outlook compared to open market sales without such a plan.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Donald Young granted Power of Attorney to Glenn Deegan (Chief Administrative Officer, General Counsel and Corporate Secretary) and Andrew Lauzon (Senior Director, Total Reward) to execute and file Forms 3, 4, and 5 on his behalf, as well as manage EDGAR filing access. | 09/22/2025 | This streamlines the process for executive SEC filings, ensuring timely compliance with Section 16(a) of the Securities Exchange Act of 1934. It is a standard corporate governance practice for executives. |
Stakeholder Impact
- Shareholders: May react to the insider sale, potentially interpreting it as a signal, though the 10b5-1 plan for personal reasons aims to clarify the intent.
Key Dates
| Date | Description |
|---|---|
| 08/11/2025 | Rule 10b5-1 trading plan adopted by Donald R. Young. |
| 09/22/2025 | Power of Attorney executed by Donald Young, appointing Glenn Deegan and Andrew Lauzon as attorneys-in-fact for SEC filings. |
| 11/13/2025 | Transaction date for the sale of common stock by Donald R. Young. |
| 11/14/2025 | Date Form 4 was signed and filed. |
Recommendation
holdWhile an insider sale by a CEO can sometimes be a negative signal, this transaction was conducted under a pre-arranged 10b5-1 plan for specific personal financial planning (tax and real estate) rather than a reflection of the company's operational performance or future outlook. Therefore, it does not provide a strong enough signal to warrant a change from a 'hold' position based solely on this filing.
Keywords
Aspen Aerogels, ASPN, Donald Young, Insider Sale, Form 4, 10b5-1 Plan, Executive Stock Transaction, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.